Search Login Register
Thromboangiitis Obliterans
(Buerger's Disease)
Summary
398
relevant articles (17 outcomes,
28 trials/studies)
found for this Disease
Description:
A non-atherosclerotic, inflammatory thrombotic disease that commonly involves small and medium-sized arteries or veins in the extremities. It is characterized by occlusive THROMBOSIS and FIBROSIS in the vascular wall leading to digital and limb ISCHEMIA and ulcerations. Thromboangiitis obliterans is highly associated with tobacco smoking.
Also Known As:
Buerger's Disease; Thromboangitis Obliterans; Buergers Disease; Disease, Buerger; Disease, Buerger's Show All >>
Key Drugs and Agents for Thromboangiitis Obliterans
Efficacy Chart >>
Drugs and Important Biological Agents (IBA) related to treatments:
-
Troleandomycin (TAO)
:
2 outcomes 7 studies in 96 results
:
FDA 2
-
Epoprostenol (Prostacyclin)
:
2 outcomes 4 studies in 11 results
:
FDA 1
-
Alprostadil (Muse)
:
2 outcomes 2 studies in 6 results
:
FDA 8
Generic
-
beraprost
:
2 outcomes 1 study in 2 results
: IBA
-
Iloprost (Ventavis)
:
1 outcome 6 studies in 11 results
:
FDA 1
-
Antigens
:
1 outcome 1 study in 8 results
: IBA
-
sarpogrelate
:
1 outcome 1 study in 2 results
: IBA
-
Serotonin (5 Hydroxytryptamine)
:
1 outcome in 4 results
: IBA
-
HLA-A9
:
1 outcome in 2 results
: IBA
-
HLA-B5
:
1 outcome in 2 results
: IBA
Show All >>
Diseases Related to Thromboangiitis Obliterans
-
Atherosclerosis (Atheroma)
-
Arteriosclerosis Obliterans
-
Ischemia
-
Pain (Aches)
-
Peripheral Vascular Diseases (Peripheral Vascular Disease)
Show All >>
Key Therapies for Thromboangiitis Obliterans
Efficacy Chart >>
-
Sympathectomy (Sympathectomies)
:
2 outcomes 2 studies in 39 results
-
Transplantation (Transplant Recipients)
:
2 outcomes in 14 results
-
Cell Transplantation
:
1 outcome 1 study in 1 result
-
Heart Valve Prosthesis
:
1 outcome 1 study in 1 result
-
Amputation
:
1 outcome in 29 results
Show All >>
CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2008 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.